Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma
Clinical trial NCT06041724 · UNKNOWN
Trial details
- NCT number
- NCT06041724
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-18
- Primary completion
- 2025-09-18
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.